---
title: 'æ•¬é€å»çš„é’æ˜¥ï¼ä¸­å¹´ç”·å­æŠ—è¡°è€çš„ä¸‰å¤§ç½©é–€(3)â€”ã€Œç¼ºç‰™ã€å¤±æ™ºç—‡é¢¨éšªé«˜ï¼'
description: 'é—œéµæ•¸å­—ã€Œ20ã€ï¼šä»¥ 4,425 ä½ 65 æ­²ä»¥ä¸Šé•·è€…ç‚ºç ”ç©¶å°è±¡è¿½è¹¤å››å¹´ï¼Œå¦‚æœè€äººçš„ç‰™é½’å°‘æ–¼ 20 é¡†è€Œä¸”æ²’æœ‰è£å‡ç‰™ï¼Œé‚£éº¼ä»–å€‘å¾—å¤±æ™ºç—‡çš„å¯èƒ½æ€§æ¯”ç‰™é½’å¤šæ–¼ 20 é¡†çš„è€äººé«˜å‡ºå°‡è¿‘ 2 å€ï¼'
pubDate: 2026-01-29
tags: ['å¥åº·', 'æŠ—è¡°è€']
---

## **ä¸­å¹´äººçš„å¥åº·ç¼ºå£ï¼Œä¸åªæ˜¯è…°åœ**

è¨±å¤šå¹´éå››åçš„ç”·æ€§ï¼Œé—œæ³¨å¿ƒè¡€ç®¡ã€é—œæ³¨é«”åŠ›ï¼Œå»å¾€å¾€å¿½ç•¥äº†å£è…”ä¸­çš„ã€Œç„¡è²å±æ©Ÿã€ã€‚

ä½ ä»¥ç‚ºç¼ºä¸€é¡†ç‰™åªæ˜¯å½±éŸ¿ç¾è§€æˆ–å’€åš¼ä¸ä¾¿å—ï¼Ÿ

æœ€æ–°çš„ç§‘å­¸ç ”ç©¶å‘Šè¨´æˆ‘å€‘ï¼šç‰™é½’çš„æ•¸é‡ï¼Œç›´æ¥é—œä¿‚åˆ°ä½ å¤§è…¦èç¸®çš„é€Ÿåº¦ã€‚

## **ç¼ºç‰™å¦‚ä½•æ‚„æ‚„å·èµ°ä½ çš„èªçŸ¥åŠŸèƒ½**

ç ”ç©¶ä¸€ï¼š**ç‰™é½’æ•¸é‡å¾ˆé‡è¦**

ç¥å¥ˆå·é½’ç§‘å¤§å­¸æ•™æˆ**å±±æœ¬é¾ç”Ÿ** ï¼ˆTatsuo Yamamotoï¼‰åœ¨è¥¿å…ƒ 2012 å¹´ã€Šèº«å¿ƒé†«å­¸ã€‹æœŸåˆŠï¼ˆPsychosomatic Medicine: Journal of Biobehavioral Medicineï¼‰ç™¼è¡¨çš„è¿½è¹¤ç ”ç©¶é¡¯ç¤ºï¼š

**é—œéµæ•¸å­—ã€Œ20ã€ï¼š** ä»¥ 4,425 ä½ 65 æ­²ä»¥ä¸Šé•·è€…ç‚ºç ”ç©¶å°è±¡è¿½è¹¤å››å¹´ï¼Œå¦‚æœè€äººçš„ç‰™é½’**å°‘æ–¼ 20 é¡†è€Œä¸”æ²’æœ‰è£å‡ç‰™** ï¼Œé‚£éº¼ä»–å€‘å¾—å¤±æ™ºç—‡çš„å¯èƒ½æ€§æ¯”ç‰™é½’å¤šæ–¼ 20 é¡†çš„è€äººé«˜å‡ºå°‡è¿‘ 2 å€ï¼

ç ”ç©¶äºŒï¼š**é˜¿èŒ²æµ·é»˜ç—‡æ‚£è€…çš„ç‰™é½’æƒ…æ³**

**ææ—©æ‰ç‰™çš„è­¦è¨Šï¼š** åå¤å±‹å¤§å­¸é†«å­¸ç ”ç©¶æ‰€çš„ä¸Šç”°å¯¦æ•™æˆåšéèª¿æŸ¥ï¼Œèª¿æŸ¥å°è±¡åŒ…å« 78 ä½å¥åº·çš„è€äººã€39 ä½æ‚£æœ‰è…¦è¡€ç®¡æ€§èªçŸ¥éšœç¤™çš„è€äººä»¥åŠ 36 ä½ç½¹æ‚£é˜¿èŒ²æµ·é»˜ç—‡çš„è€äººã€‚

çµæœç™¼ç¾å¾—ç—…çš„è€äººå¹³å‡åªæœ‰å¥åº·è€äºº 1/3 çš„ç‰™é½’ï¼Œè€Œä¸”å¾—ç—…çš„è€äººæ¯”å¥åº·è€äººæ—©äº† 20 å¹´å°±é–‹å§‹æ‰ç‰™ï¼

Screenshot

ç ”ç©¶ä¸‰ï¼š**å’€åš¼æ˜¯è…¦éƒ¨çš„ã€Œå¤©ç„¶å¹«æµ¦ã€**

è¥¿å…ƒ 2012 å¹´ç™¼è¡¨æ–¼ã€Šç¾åœ‹è€äººé†«å­¸å­¸æœƒæœŸåˆŠã€‹ï¼ˆJournal of the American Geriatrics Societyï¼‰ç‘å…¸çš„ç§‘å­¸å®¶ä¹Ÿç™¼ç¾ï¼š

å¦‚æœè€äººç¼ºå°‘å¾ˆå¤šç‰™é½’æˆ–æ˜¯æ²’è¾¦æ³•å’¬ç¡¬çš„é£Ÿç‰©ï¼ˆæ¯”å¦‚è˜‹æœï¼‰ï¼Œå¯èƒ½æœƒå½±éŸ¿ä»–å€‘çš„è¨˜æ†¶åŠ›ã€åšæ±ºå®šçš„èƒ½åŠ›ï¼Œä»¥åŠè§£æ±ºå•é¡Œçš„èƒ½åŠ›ã€‚

## **ç¼ºç‰™å°è‡´å’€åš¼æ¬¡æ•¸æ¸›å°‘**

ç‚ºä»€éº¼ç¼ºç‰™å’Œå¤±æ™ºç—‡é—œä¿‚é€™éº¼å¯†åˆ‡ï¼Ÿ

ä¸­è¯æ°‘åœ‹é¡å’¬åˆå­¸æœƒæš¨å¯©ç¾ç‰™é†«å­¸æœƒå‰µæœƒæœƒé•·æ—å´‡æ°‘è§£é‡‹ï¼Œç‰™é½’èˆ‡é½’æ§½éª¨é–“ï¼Œæœ‰ä¸€ç³»åˆ—åç‚ºç‰™å‘¨è†œçš„æ‡¸åŠéŸŒå¸¶é€£çµå…©è€…ã€‚

ç•¶æˆ‘å€‘ä¸€å’€åš¼ï¼Œç‰™æ ¹å°±æœƒåœ¨å—åŠ›å¾Œå¾€ä¸‹æ–½å£“ï¼Œè®“ç‰™å‘¨è†œå…§çš„å¾®è¡€ç®¡è·Ÿè‘—è¢«å£“ç¸®ï¼Œåˆºæ¿€è¡€æ¶²å›æµå¤§è…¦ã€‚

äº‹å¯¦ä¸Šï¼Œé€™å€‹å’€åš¼çš„å‹•ä½œé™¤äº†èƒ½åˆºæ¿€è¡€æ¶²å›æµï¼Œä¹Ÿæœƒå½±éŸ¿å¤§è…¦å…§åŒ…å«æµ·é¦¬è¿´åŠç°è³ªç­‰èˆ‡è¨˜æ†¶åŠèªçŸ¥æœ‰é—œçš„å€åŸŸã€‚

ä¸€æ—¦ç™¼ç”Ÿç¼ºç‰™çš„æƒ…å½¢ï¼Œå’€åš¼åŠ›å°±æœƒé–‹å§‹ä¸‹æ»‘ï¼Œç¼ºçš„ç‰™é½’æ„ˆå¤šï¼Œä¸‹æ»‘å¾—æ„ˆåš´é‡ã€‚

è¥¿å…ƒ 2020 å¹´åœ¨ã€Šè€åŒ–ã€‹ï¼ˆAgingï¼‰æœŸåˆŠå…¬å¸ƒä¸€ä»½é•·é” 22 å¹´çš„ç ”ç©¶å ±å‘Šï¼Œé€™ä»½å ±å‘Šè¿½è¹¤äº† 554 ä½ 50 æ­²ä»¥ä¸Šçš„å°è±¡ï¼›

çµæœé¡¯ç¤ºå’€åš¼èƒ½åŠ›ä¸‹é™çš„ç¨‹åº¦èˆ‡å¹´é½¡å¢é•·å¾Œçš„æ™ºåŠ›è¡°é€€å‘ˆæ­£ç›¸é—œï¼Œä¹Ÿå°±æ˜¯**å’€åš¼èƒ½åŠ›æ„ˆå·®ï¼Œæ™ºåŠ›è¡°é€€çš„æƒ…æ³æ„ˆæ˜é¡¯** ã€‚

ä¸€æ—¦å¤±å»å’€åš¼èƒ½åŠ›ï¼Œè…¦éƒ¨è¡€æµé‡æ¸›å°‘ï¼Œå¤§è…¦å¤±å»åˆºæ¿€ï¼Œå°±å®¹æ˜“ç”¢ç”Ÿé€€åŒ–ã€‚

## **ç‰™å‘¨ç—…æ˜¯æ‰ç‰™ä¸»å› **

å£è…”æ˜¯å…¨èº«å­˜åœ¨æœ€å¤šç¨®ç´°èŒçš„åœ°æ–¹ï¼Œè€Œç‰™å‘¨ç—…æ˜¯ç‰™é½’å‘¨åœçš„ç–¾ç—…ï¼Œç‰™å‘¨ç—…å¦‚æœæ²’æœ‰æ²»ç™‚ï¼Œç´°èŒæœƒéš¨è‘—è¡€æ¶²å¾ªç’°ï¼Œå¾å£è…”è”“å»¶åˆ°èº«é«”å…¶ä»–å™¨å®˜ï¼Œé€ æˆå…¨èº«é‡è¦å™¨å®˜çš„è² æ“”ï¼ŒåŠ é‡åŸæœ‰çš„ç–¾ç—…ã€‚

ç‰™å‘¨ç—…ä¸»è¦æˆå› æœ‰ä¸‰ï¼š

  * æ˜¯é™„è‘—åœ¨ç‰™é½’ä¸Šçš„**ç‰™èŒæ–‘** é•·æœŸå †ç©å¼•ç™¼ç‰™é½¦ç´…è…«ç™¼ç‚ã€æµè¡€åŠé½’æ§½éª¨ç ´å£ï¼Œç‰™ç¸«è®Šå¤§ï¼Œç‰™é½’å‹•æ–ï¼Œçµ‚è‡³å¤±å»ç‰™é½’ï¼›
  * ç”Ÿæ´»ç¿’æ…£ä¸ä½³ï¼Œç†¬å¤œã€æŠ½è¸ã€ç³–å°¿ç—…ç­‰æœƒè®“èº«é«”æŠµæŠ—åŠ›ä¸‹é™ï¼Œç´°èŒå°±æœ‰æ©Ÿå¯è¶ï¼›
  * éºå‚³åŸºå› æœ‰é—œï¼Œæ ¹æ“šåˆ†å­æµè¡Œç—…å­¸ç ”ç©¶ï¼Œç‰™å‘¨ç—…æœƒç¶“ç”±çˆ¶æ¯å‚³çµ¦å­å¥³ï¼Œä¹Ÿæœ‰éºå‚³å­¸çš„ç ”ç©¶è­‰å¯¦æŸäº›èˆ‡ç‰™å‘¨ç—…æœ‰é—œçš„åŸºå› æœƒéºå‚³çµ¦ä¸‹ä¸€ä»£ã€‚
  * **ç‰™é½¦èç¸®æ˜¯ç‰™å‘¨ç—…çš„è­¦è¨Šä¹‹ä¸€** ï¼Œå¦‚æœå£è…”è¡›ç”Ÿä¸ä½³ï¼Œæ²’æœ‰è‰¯å¥½çš„æ½”ç‰™ç¿’æ…£ï¼Œç‰™èŒæ–‘æœƒæ¼¸æ¼¸ç´¯ç©æˆç‰™çµçŸ³ï¼Œé€ æˆç‰™é½¦ç‚èˆ‡ç‰™å‘¨ç—…ã€‚

ç‰™é½¦å‡ºè¡€æ˜¯ç‰™é½¦èç¸®çš„æ—©æœŸä¿¡è™Ÿä¹‹ä¸€ã€‚

ç•¶ç‰™é½’æœªç¶“å¦¥å–„æ¸…æ½”ï¼Œç´°èŒèˆ‡é£Ÿç‰©æ®˜æ¸£å°‡èšé›†æ–¼ç‰™é½’è¡¨é¢ã€ç‰™é½’åŠç‰™é½¦é–“éš™ï¼Œå½¢æˆ**ç‰™èŒæ–‘** ï¼ˆDental Plaqueï¼‰ï¼Œç‰™èŒæ–‘æ—¥ç©æœˆç´¯è€Œéˆ£åŒ–æˆ**ç‰™çµçŸ³** ï¼Œé€ æˆç‰™é½¦ç™¼ç‚ç´…è…«ç”šè‡³æµè¡€ï¼Œæ­¤æ™‚ç¨±ç‚º**ç‰™é½¦ç‚** ï¼›

è‹¥æ˜¯æ‚£è€…æœªåŠæ™‚è™•ç½®ï¼Œç‰™å‘¨ç—…ä¸åƒ…æœƒä½¿ç‰™é½¦èç¸®ï¼Œæ›´æœƒé€£å¸¶æç©ºä¸‹æ–¹éª¨è³ªï¼Œé€ æˆåš´é‡çš„**ç‰™å‘¨ç‚** ã€‚

ç‰™å‘¨ç—…èµ·åˆå¤§å¤šæ²’æœ‰ä»€éº¼ç—‡ç‹€ï¼Œå› æ­¤å®¹æ˜“è¢«å¿½ç•¥ï¼Œä¹…è€Œä¹…ä¹‹æ‚£è€…å°‡æœƒæ¼¸æ¼¸å‡ºç¾ç‰™é½¦å‡ºè¡€ã€ç‰™é½¦è…«è„¹ã€ç‰™é½¦èç¸®ã€ç‰™é½’æ–å‹•ã€æ•æ„Ÿç‰™é½’ã€å‡ºç¾å£è‡­ç­‰å•é¡Œï¼Œæœ‰ç›¸é—œç—‡ç‹€å‡ºç¾å°±è©²ç›¡æ—©æª¢æŸ¥ä¸¦æ²»ç™‚ï¼Œæ­¤æ™‚è‹¥é‚„ç„¡æ‰€è­¦è¦ºï¼Œæœ€å¾Œå°±æ˜¯**æ‰ç‰™** ã€‚

## **ç‰™å‘¨ç—…å’Œé˜¿èŒ²æµ·é»˜ç—‡é—œè¯**

ç ”ç©¶ç‰™å‘¨ç—…å’Œé˜¿èŒ²æµ·é»˜ç—‡é—œè¯æ€§çš„æŒªå¨å‘çˆ¾æ ¹å¤§å­¸ï¼ˆUniversity of Bergenï¼‰å­¸è€…éº¥å¾·çˆ¾ï¼ˆPiotr Mydelï¼‰èªªï¼Œé˜¿èŒ²æµ·é»˜çš„æˆå› ï¼Œé›–ç„¶ä¸èƒ½å…¨æ­¸å’ç‰™é½’çš„ç´°èŒï¼Œä½†æ ¹æ“šä»–å’Œç ”ç©¶åœ˜éšŠã€è§£æ 53 åé˜¿èŒ²æµ·é»˜ç—…æ‚£çš„è…¦éƒ¨çµ„ç¹”å’Œå”¾æ¶²ï¼Œçµæœç™¼ç¾è¶…é 9 æˆç—…æ‚£éƒ½å«æœ‰åç‚º**ç‰™é½¦åŸå•‰å–®èƒèŒ** ï¼ˆPorphyromonas gingivalis ï¼Œ _P_._gingivalis_ ï¼‰çš„ç´°èŒã€‚

é€™æ˜¯ä¸€ç¨®é©è˜­é™°æ€§å­æ°§èŒï¼Œé€é DNA ç ”ç©¶ç™¼ç¾ï¼Œç´¯ç©åœ¨ç‰™é½’çš„ç‰™èŒæ–‘ï¼Œé€ æˆç‰™é½¦ç™¼ç‚ï¼Œç•¶ç´°èŒç§»åˆ°è…¦éƒ¨æ™‚ï¼Œæœƒç”¢ç”Ÿç•°å¸¸çš„è›‹ç™½è³ªï¼Œç ´å£ç¥ç¶“ç´°èƒï¼Œå°è‡´è…¦éƒ¨è¨˜æ†¶é€€åŒ–ï¼Œæœ€å¾Œæƒ¡åŒ–æˆé˜¿èŒ²æµ·é»˜ç—‡ã€‚

å¦å¤–ç¾åœ‹ä½›ç¾…é‡Œé”å¤§å­¸å‰¯æ•™æˆ**æŸ¯è–©ç“¦è·¯** ï¼ˆLakshmyya Kesavaluï¼‰æ‰€é ˜å°çš„ç ”ç©¶åœ˜éšŠï¼Œåœ¨å°ç”Ÿå‰ç½¹æ‚£é˜¿èŒ²æµ·é»˜ç—‡æ‚£è€…çš„è…¦éƒ¨é€²è¡Œæª¢æŸ¥æ™‚ç™¼ç¾äº†ç‰™å‘¨ç—…ä¸»è¦è‡´ç—…èŒâ€”â€”ç‰™é¾ˆåŸå•‰å•èƒèŒæ‰€ç”¢ç”Ÿçš„**è„‚å¤šç³–** ï¼ˆLipopolysaccharideï¼ŒLPSï¼‰æ¯’ç´ ã€‚

ç›¸è¼ƒä¹‹ä¸‹ï¼Œæœªç½¹æ‚£é˜¿èŒ²æµ·é»˜ç—‡çš„äººè…¦ä¸­ä¸¦æœªæª¢æ¸¬åˆ° LPS çš„å­˜åœ¨ã€‚

## **å¥½å¥½æ½”ç‰™å¤±æ™ºç—‡æ°æ°**

åœ¨æ—©æœŸç‰™é½’å°±è¦å¥½å¥½ä¿è­·ï¼Œå¾ç”Ÿæ´»ç•¶ä¸­å°±èƒ½åšåˆ°ï¼Œé‚£å°±æ˜¯ã€Œå‹¤åˆ·ç‰™ã€ç”¨ç‰™ç·šã€‚ã€

æœ‰é—œåˆ·ç‰™çš„é »ç‡ï¼Œç‰™é†«å¸«å€‘éƒ½å»ºè­°åªè¦**åƒå®Œæ±è¥¿å°±åˆ·** ï¼Œæ˜¯ç¢ºä¿å£è…”æ¸…æ½”çš„æœ€å¥½æ–¹å¼ã€‚

å¦å¤–**æˆå¹´äººæ¯åŠå¹´åˆ°ä¸€å¹´æª¢æŸ¥ä¸€æ¬¡** ï¼Œ**è€å¹´äººå‰‡æ¯åŠå¹´å°±è¦æª¢æŸ¥ä¸€æ¬¡** ï¼Œä¸è¦æ‡¶åˆæ€•éº»ç…©éƒ½ä¸å»æ´—ç‰™ï¼ï¼

### **æ­£ç¢ºçš„åˆ·ç‰™æ–¹æ³•**

æ¡ç”¨**è²æ°åˆ·ç‰™æ³•** ï¼Œæ‰‹æ¡ç‰™åˆ·ï¼Œæ‹‡æŒ‡å‰ä¼¸ï¼Œç‰™åˆ·åˆ·æ¯›èˆ‡ç‰™é½’æˆ 45 åº¦æ–œè§’ï¼Œç”±ä¸Šåˆ°ä¸‹ï¼Œç”±å¤–åˆ°å…§éƒ½è¦åˆ·ï¼Œå‰å¾Œç´„è¦èŠ±ä¸Š 3 åˆ†é˜çš„æ™‚é–“ã€‚

ä»¥å…©é¡†ç‰™é½’ç‚ºå–®ä½ï¼Œå·¦å³ä¾†å›è¼•è¼•åˆ·ç´„åæ¬¡ï¼Œæ¯å€‹é¢éƒ½è¦åˆ·åˆ°ã€‚ 

### **é¸æ“‡é©ç•¶ç‰™åˆ·**

ç‰™åˆ·é¸æ“‡åˆ·é ­**è¼ƒå°** ã€åˆ·æ¯›**æŸ”è»Ÿ** è€…ï¼Œå¦‚æ­¤ä¸æ˜“æè€—ç‰™é½’ï¼Œä¸¦ä¸”èƒ½è¼ƒéˆæ´»æ¸…æ½”ã€‚

åˆ·æ¯›ä¸éœ€è¦å¤ªå¯†é›†ï¼Œå¦å‰‡å®¹æ˜“é€ æˆé£Ÿç‰©æ®˜æ¸£æ®˜ç•™ã€‚

ç‰™åˆ·æ¯ä¸‰å€‹æœˆè¦æ›´æ›ï¼Œå¦‚æœåˆ·æ¯›éƒ½é–‹èŠ±äº†åˆ‡è¨˜ä¸è¦ç‚ºäº†çœéŒ¢éƒ½ä¸æ›ã€‚

### **æ­é…ä½¿ç”¨ç‰™ç·šã€ç‰™é–“åˆ·ã€æ¼±å£æ°´**

åœ¨ä¸æ–¹ä¾¿åˆ·ç‰™çš„æƒ…æ³ä¸‹ï¼Œä½¿ç”¨ç‰™ç·šæˆ–ç‰™é–“åˆ·ï¼Œä¹Ÿèƒ½å¹«åŠ©å»é™¤é½’ç¸«çš„é£Ÿç‰©æ®˜æ¸£ã€‚

ç¡å‰çš„æ½”ç‰™å·¥ä½œï¼Œæœ€å¥½ç‰™åˆ·ã€ç‰™ç·šæˆ–ç‰™é–“åˆ·ä¸¦ç”¨ã€‚

æ¼±å£æ°´å‰‡æ˜¯å¯æš«æ™‚å¹«åŠ©å£è…”æ®ºèŒåŠç¶­æŒå£æ°£æ¸…æ–°ï¼Œä½†æ˜¯ï¼Œä½†é€™ä¸‰è€…éƒ½ä¸èƒ½å–ä»£ç‰™åˆ·èˆ‡ç‰™è†çš„æ¸…æ½”ã€‚

### **æ³¨æ„ç‰™è†æˆåˆ†**

å°‡æ°ŸåŒ–ç‰©ï¼ˆé€šå¸¸æ˜¯æ°Ÿç£·é…¸éˆ‰ Sodium Monofluorophosphateï¼ŒMFPï¼ŒNa2FPO3ï¼‰æ·»åŠ åˆ°ç‰™è†å…§ï¼Œåˆ·ç‰™æ™‚ç‰™è†æœƒè§£é›¢ç”¢ç”Ÿæ°Ÿé›¢å­ï¼›è€Œ**æ°Ÿé›¢å­å¯ä»¥å’Œç‰™é½’è¡¨é¢çµåˆç”¢ç”Ÿè¼ƒå®¹æ˜“æŠµæŠ—é…¸çš„æ°Ÿç£·é…¸éˆ£** ã€‚

ç ”ç©¶é¡¯ç¤ºè‡³å°‘æ°Ÿå«é‡å¤§æ–¼ 1000ppm æ‰èƒ½ç¢ºå¯¦é é˜²è›€ç‰™ã€‚

å¦å¯é¸æ“‡é«˜é»åº¦çš„å‡è† é¡çš„ç‰™è†ï¼Œè¼ƒèƒ½ä¿ç•™æ–¼å£è…”ä¸­ä»¥ç™¼æ®åŠŸæ•ˆã€‚

## **æ¨è–¦ AP 24Â® ç‰™è†ä¾†ä¿è­·ä½ çš„ç‰™é½’**

AP 24Â®ä¸å«éæ°§åŒ–ç‰©ä»¥ç¨ç‰¹é…æ–¹å¹«åŠ©æ½”ç™½ç‰™é½’ï¼Œå¸¶æœ‰é¦™è‰è–„è·é¢¨å‘³ï¼Œè®“å£é½’æ¸…çˆ½æ½”æ·¨ï¼Œå°å­©ã€å­•å©¦éƒ½å¯ä»¥æ”¾å¿ƒä½¿ç”¨ã€‚

æ­é…æ­£ç¢ºåˆ·ç‰™ç¿’æ…£ï¼Œå¯é•·æ™‚é–“æ¸›å°‘ç‰™èŒæ–‘ç”¢ç”Ÿã€‚

  * **ç„¦ç£·é…¸å››éˆ‰** ï¼ˆTetrasodium Pyrophosphateï¼‰ï¼šå¹«åŠ©æ¸›å°‘å’–å•¡ã€èŒ¶æ¼¬ã€é¦™ç…™ç­‰åœ¨é½’é¢è‰²ç´ æ®˜ç•™ã€æ¸›å°‘ç‰™å¢ã€‚
  * **æ°´åˆäºŒæ°§åŒ–çŸ½** ï¼ˆHydrated Silicaï¼ŒSilicondioxidehydrateï¼‰ã€**æ°§åŒ–é‹** ï¼ˆAluminum Hydroxideï¼‰ï¼šä»¥æ¥µç´°å¾®çš„é¡†ç²’å»é™¤å¸é™„é½’é¢é»è‘—çš„è‰²ç´ ï¼Œåˆ©ç”¨æ‘©æ“¦å»æ±¡ï¼Œé”åˆ°è¡¨é¢æ¸…æ½”æ•ˆæœï¼›ä¸ä½¿ç”¨éæ°§åŒ–ç‰©ï¼ˆHydrogen Peroxideï¼‰ä¾†æ°§åŒ–é‚„åŸå»é™¤æŸ“è‰²ã€‚
  * å°ˆåˆ©AP 24Â®ç¨ç‰¹é…æ–¹ï¼ˆå°ˆåˆ©èšäºŒç”²åŸºç¡…æ°§çƒ·ä¹³åŠ‘ï¼ˆDimethiconeï¼‰åŠç•Œé¢æ´»æ€§åŠ‘ï¼ˆPoloxamer 407 & 338ï¼‰ï¼‰ï¼šé•·æ•ˆæ½”ç‰™æ´»æ€§æˆåˆ†ï¼Œæ¸›å°‘ç‰™èŒæ–‘ç”¢ç”Ÿã€‚
  * **å–®æ°Ÿç£·é…¸éˆ‰** ï¼ˆSodium monofluorophosphateï¼‰ï¼šå¯ä¿è­·ç‰™é½’ï¼Œé™ä½é½²é½’ç™¼ç”Ÿæ©Ÿç‡ã€‚ç ”ç©¶ä¸Šé¡¯ç¤ºæ°ŸåŒ–ç‰©å¯ä»¥å’Œç‰™é½’çš„çºç‘¯è³ªçµåˆï¼Œé€²è€Œç™¼æ®é é˜²è›€ç‰™çš„æ•ˆæœã€‚
  * **äºŒæ°§åŒ–éˆ¦** ï¼ˆTitanium Dioxide (CI 77891ï¼‰ï¼‰ï¼šç‰™é½’äº®ç™½æˆåˆ†ï¼Œç²˜é™„åŠ›å¼·ï¼Œä¸æ˜“èµ·åŒ–å­¸è®ŠåŒ–ã€‚
  * AP 24Â®æ½”ç™½ç‰™è†æ¦®ç²ç”Ÿç­–æœƒåœ‹å®¶å“è³ªæ¨™ç« 

Screenshot

è‡ªå·±åŠ å…¥è‡ªå·±è²·ï¼šğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡

> [æˆç‚º Nu Skin è‡ªç”¨æœƒå“¡è¶…ç°¡å–®ï¼Œå®Œå…¨å…è²»çœ‹åœ–å°±æœƒï¼](https://agelocked.com/%e6%88%90%e7%82%ba-nu-skin-%e8%87%aa%e7%94%a8%e6%9c%83%e5%93%a1%e8%b6%85%e7%b0%a1%e5%96%ae%ef%bc%8c%e5%ae%8c%e5%85%a8%e5%85%8d%e8%b2%bb%e7%9c%8b%e5%9c%96%e5%b0%b1%e6%9c%83%ef%bc%81/)

åƒè€ƒè³‡æ–™ï¼š  
01.The News Lensé—œéµè©•è«–/é„­å´‡ä½‘/[ã€Œå¾å¹´æœªå››åï¼Œè€Œè¦–èŒ«èŒ«ï¼Œè€Œé«®è’¼è’¼ï¼Œè€Œé½’ç‰™å‹•æ–ã€ï¼Œç³–å°¿ç—…ç‚ºä½•è®“éŸ“æ„ˆè½å¾—å¦‚æ­¤ä¸‹å ´ï¼Ÿ](https://www.thenewslens.com/article/158885)  
02.MYFEEL/å“æ„Ÿè¦º/[å°ç£åœ‹ç—…ä¹‹ä¸€ï¼40%ä»¥ä¸Šçš„äººè¦éç¼ºç‰™ç”Ÿæ´»15å¹´ï¼](https://www.myfeel-tw.com/tw/media/articles/619355d62e6bad6469318acd/sick-teeth)  
03\. Tatsuo Yamamoto, Katsunori Kondo, Hiroshi Hirai, Miyo Nakade, Jun Aida, Yukio Hirata, 2012. [Association between self-reported dental health status and onset of dementia: a 4-year prospective cohort study of older Japanese adults from the Aichi Gerontological Evaluation Study (AGES) Project.](https://pubmed.ncbi.nlm.nih.gov/22408130/) _Psychosom Med._ 74(3):241-8.  
04\. Hiroyuki Nakamura, Moeko Noguchi-Shinohara, Mai Ishimiya-Jokaji, Yutaka Kobayashi, Mikana Isa, Kentaro Ide, Toshihiro Kawano, Shuichi Kawashiri, Kazuhiro Uchida, Yasuko Tatewaki, Yasuyuki Taki, Tomoyuki Ohara, Toshiharu Ninomiya, Kenjiro Ono, 2024. [Brain atrophy in normal older adult links tooth loss and diet changes to future cognitive decline.](https://pubmed.ncbi.nlm.nih.gov/38519528/) _NPJ Aging._ 10(1):20.  
05\. Sophie Poole, Sim K Singhrao, Lakshmyya Kesavalu, Michael A Curtis, StJohn Crean, 2013. [Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimerâ€™s disease brain tissue.](https://pubmed.ncbi.nlm.nih.gov/23666172/)  _J Alzheimers Dis._ 36(4):665-77.  
06\. Sim K Singhrao, Alice Harding, Sophie Poole, Lakshmyya Kesavalu, StJohn Crean, 2015. [Porphyromonas gingivalis Periodontal Infection and Its Putative Links with Alzheimerâ€™s Disease.](https://pubmed.ncbi.nlm.nih.gov/26063967/) _Mediators Inflamm._ 137357.  
07\. Mariarita Stirpe, Benedetta Brugnoli, Gianfranco Donelli, Iolanda Francolini, Claudia Vuotto, 2020. [Poloxamer 338 Affects Cell Adhesion and Biofilm Formation in  _Escherichia coli_ : Potential Applications in the Management of Catheter-Associated Urinary Tract Infections.](http://Mariarita Stirpe 1, Benedetta Brugnoli 2, Gianfranco Donelli 1, Iolanda Francolini 2, Claudia Vuotto 1) _Pathogens_. 9(11):885.  
08\. Lucia Henrici De Angelis, Mariarita Stirpe, Dario Tomolillo, Gianfranco Donelli, Iolanda Francolini, Claudia Vuotto, 2022. [The Multifunctional Role of Poloxamer P338 as a Biofilm Disrupter and Antibiotic Enhancer: A Small Step forward against the Big Trouble of Catheter-Associated  _Escherichia coli_ Urinary Tract Infections.](https://pubmed.ncbi.nlm.nih.gov/36144359/) _Microorganisms._ 31;10(9):1757.  
09\. Enas Al-Ani, Wayne Heaselgrave, 2022. [The Investigation of Thymol Formulations Containing Poloxamer 407 and Hydroxypropyl Methylcellulose to Inhibit Candida Biofilm Formation and Demonstrate Improved Bio-Compatibility. ](https://pubmed.ncbi.nlm.nih.gov/35056128/)_Pharmaceuticals (Basel)._ 15(1):71.

å–œæ­¡æˆ‘å¯«çš„å…§å®¹å—?  
è«‹é»é¸åŠ å…¥å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤å°ˆå€å‘Šè¨´æˆ‘ä½ çš„æ„Ÿæƒ³èˆ‡è©•è«– ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡  

[ å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤æœƒå“¡å°ˆå€ ](https://lin.ee/jgugMvX)

æƒ³ç¬¬ä¸€æ‰‹æ¥æ”¶ç”¢å“å¿«è¨Šèˆ‡ç§‘å­¸æ–°çŸ¥å—ï¼Ÿ  
æœ‰æ­é…å¦‚æ–°ä¿å¥å“å•é¡Œæƒ³å•å—ï¼Ÿ  
è«‹é»é¸åŠ å…¥å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤å°ˆå€åšè«®è©¢ ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡  

[ å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤æœƒå“¡å°ˆå€ ](https://lin.ee/jgugMvX)